Inositol

insulin ; Homo sapiens







178 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
151 16492584 Inositol phosphoglycan putative insulin mediator in human amniotic fluid. 2006 Jan 1
152 14715857 Metformin therapy increases insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator in women with polycystic ovary syndrome. 2004 Jan 2
153 12917943 Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome. 2003 1
154 14642843 D-chiro-Inositol enhances effects of hypothalamic toxin gold-thioglucose. 2003 Dec 12 3
155 11900279 D-chiro-inositol--its functional role in insulin action and its deficit in insulin resistance. 2002 9
156 11937980 [Polycystic ovary syndrome: treatment with insulin-sensitizing agents]. 2002 Feb 1
157 12458657 Fasting decreases the content of D-chiroinositol in human skeletal muscle. 2002 Jul-Sep 1
158 15251831 Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome. 2002 Nov-Dec 4
159 11280715 Relationships of plasma C-peptide and gender to the urinary excretion of inositols in older people. 2001 Jan 11
160 11497481 Use of insulin-sensitizing agents in patients with polycystic ovary syndrome. 2001 Jul-Aug 2
161 11547915 D-chiro-inositol in insulin action and insulin resistance-old-fashioned biochemistry still at work. 2001 Mar 1
162 11117673 Role of inositolphosphoglycan mediators of insulin action in the polycystic ovary syndrome. 2000 1
163 10219066 Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. 1999 Apr 29 5
164 10501653 Diabetes and the role of inositol-containing lipids in insulin signaling. 1999 Aug 2
165 10212830 Phosphoinositol glycan derived mediators and insulin resistance. Prospects for diagnosis and therapy. 1998 3
166 8772575 Circulating factors and insulin resistance. II. The action of the novel myo-inositol cyclic 1,2-inositol phosphate phosphoglycan insulin antagonist from human plasma in regulating pyruvate dehydrogenase phosphatase. 1996 Mar 1
167 7629237 Circulating factors and insulin resistance. I. A novel myoinositol 1,2-cyclic phosphate phosphoglycan insulin antagonist from human plasma is elevated in noninsulin-dependent diabetes mellitus. 1995 Aug 1
168 7882818 Urinary chiro-inositol excretion is an index marker of insulin sensitivity in Japanese type II diabetes. 1994 Dec 2
169 8234346 D-chiro-inositol metabolism in diabetes mellitus. 1993 Nov 1 4
170 8356081 Insulin stimulates the biosynthesis of chiro-inositol-containing phospholipids in a rat fibroblast line expressing the human insulin receptor. 1993 Aug 15 3
171 8392181 chiro-inositol deficiency and insulin resistance: a comparison of the chiro-inositol- and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects. 1993 Jul 1 2
172 8425483 Chiroinositol deficiency and insulin resistance. I. Urinary excretion rate of chiroinositol is directly associated with insulin resistance in spontaneously diabetic rhesus monkeys. 1993 Feb 2
173 1936592 Differential regulation of glycosylated phosphatidylinositol subtypes by insulin. 1991 Oct 1
174 2370888 Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus. 1990 Aug 9 4
175 2851976 Insulin provokes co-ordinated increases in the synthesis of phosphatidylinositol, phosphatidylinositol phosphates and the phosphatidylinositol-glycan in BC3H-1 myocytes. 1988 Nov 15 1
176 3016898 Insulin-stimulated hydrolysis of a novel glycolipid generates modulators of cAMP phosphodiesterase. 1986 Aug 29 1
177 6337138 Effects of insulin on phenylephrine-induced activation of phosphorylase and phosphatidylinositol turnover in isolated hepatocytes. 1983 Feb 10 1
178 838172 Myoinositol metabolism in diabetes mellitus. Effect of insulin treatment. 1977 Mar 3